| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |